Table 4 Short-term postoperative outcome, 90-day graft and patient survival of EAD and non-EAD patients
Whole cohort (n = 231) | Study cohort (n = 110) | Non-EAD (n = 62) | EAD (n = 48) | p-value | |
|---|---|---|---|---|---|
Severity of IRI (peak ALT/AST)* | 1358 (570–3191) | 1506 (583–3881) | 681 (334–1195) | 4395 (3443–7605) | < 0.001 |
Overall major complication** | 109 (47.2%) | 65 (59.1%) | 33 (53.2%) | 32 (66.7%) | 0.155 |
Reoperation | 62 (26.8%) | 44 (40%) | 18 (29.0%) | 26 (54.2%) | 0.008 |
Postoperative RRT | 96 (41.6%) | 58 (52.7%) | 29 (46.8%) | 29 (60.4%) | 0.155 |
Arterial complications | 11 (4.8%) | 7 (6.4%) | 1 (1.6%) | 6 (12.5%) | 0.042 |
Hepatic artery thrombosis | 5 (2.2%) | 3 (2.7%) | 0 | 3 (6.3%) | 0.080 |
Biliary complications | 37 (16%) | 17 (15.5%) | 9 (14.5%) | 8 (16.7%) | 0.757 |
ICU length of stay (days) | 3 (2–5) | 3 (2–5) | 3 (2–5) | 4 (2–9) | 0.005 |
Hospital length of stay (days) | 16 (12–23) | 17 (13–22) | 17 (13–22) | 17 (13–24) | 0.805 |
90-day outcome | |||||
90-day graft survival | 213 (92.2%) | 97 (88.2%) | 59 (95.2%) | 38 (79.2%) | 0.01 |
90-day patient survival | 215 (93.1%) | 99 (90.0%) | 59 (95.2%) | 40 (83.3%) | 0.055 |